Canopy Growth Corporation·Healthcare

Marijuana stock investors who have been trading and holding over the years know this sector holds potential. Now, potential doesn't put money in your pocket, but progressive and profitable companies that make up the industry can, which means that there is a lot of potential to see big gains in the future with all that is taking place. For the USA, there are only a few states that have yet to legalize cannabis. Just the legal states alone in 2026 have brought in a billion in revenue.

Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.

In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.02, marking a +2% move from the previous day.

The Canadian cannabis sector continues evolving as global opportunities expand. Many companies are now positioning for U.S. entry. Additionally, federal reform discussions in the United States remain a major catalyst. As a result, investors are closely watching key Canadian names. However, volatility remains high, so proper risk management is essential.

SMITH FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced Deelish ("DEE-LISH"), a new cannabis brand built for the everyday consumer with an everyday price. Deelish enters the market built to deliver high THC with flower testing at 27%-33% THC and pre-rolls at 26%-32% THC. And unlike brands built around a single profile, Deelish rotates its genetic lineup regularly, giving consumers access to a curated range of.

Marijuana legalization in the U.S. isn't likely to happen anytime soon, and that's weighing on Canopy Growth's stock. The company's results have been abysmal, and there's little reason to be optimistic that they'll improve anytime soon.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
1,029
2014-04-07
2.32